UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10003, pp. 1537 - 1545
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzofurans - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Male | Treatment Outcome | Hepatitis C, Chronic - complications | Renal Insufficiency, Chronic - complications | Hepatitis C, Chronic - drug therapy | Renal Insufficiency, Chronic - drug therapy | RNA, Viral | Female | Aged | Imidazoles - therapeutic use | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Quinoxalines - therapeutic use | Hypertension | Medical research | Surfers | Care and treatment | Chronic kidney failure | Gastrointestinal diseases | Liver | Medicine, Experimental | Genetic aspects | Hepatitis C virus | Health aspects | Analysis | Hepatitis | Interferon | Kidney diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1075 - 1086
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Hepacivirus - genetics | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Polyethylene Glycols - therapeutic use | Viral Load | Young Adult | Ribavirin - administration & dosage | Treatment Failure | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Liver Cirrhosis - etiology | Drug Administration Schedule | Quinoxalines - administration & dosage | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Adolescent | Aged | Medical colleges | Protease inhibitors | Proteases | Clinical trials | Product development | Biological response modifiers | Hepatitis C virus | Health aspects | Liver cirrhosis | Ribavirin | Comparative studies | Hepatitis | Genotype & phenotype | Interferon | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | UNITED-STATES | SOFOSBUVIR | RIBAVIRIN | Klinisk medicin | SUSTAINED VIROLOGICAL RESPONSE | Medicine | Clinical Medicine | HCV NS5A INHIBITOR | TREATMENT-EXPERIENCED PATIENTS | DISEASE BURDEN | General & Internal | DOUBLE-BLIND | INTERFERON-ALPHA 2A | TREATMENT-NAIVE PATIENTS | PLUS
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1087 - 1097
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Coinfection | Quinoxalines - administration & dosage | Humans | Middle Aged | Hepacivirus - genetics | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Treatment Outcome | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Viral Load | Young Adult | Ribavirin - administration & dosage | HIV Infections - complications | Adult | Female | Aged | Drug Therapy, Combination | Medical colleges | Care and treatment | Protease inhibitors | Proteases | Product development | Cross infection | Nosocomial infections | Hepatitis C virus | Health aspects | Hepatitis | Genotype & phenotype | Human immunodeficiency virus--HIV | Mortality | Comparative studies | Interferon | Infections | Drug therapy | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 1 - 13
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Quinoxalines - adverse effects | Nausea - chemically induced | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Fatigue - chemically induced | Hepatitis C, Chronic - complications | Viral Load | Young Adult | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Headache - chemically induced | Quinoxalines - therapeutic use | Benzofurans - therapeutic use | Drug Administration Schedule | Administration, Oral | Antiviral Agents - therapeutic use | Liver Cirrhosis - complications | Imidazoles - adverse effects | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Benzofurans - adverse effects | Antiviral Agents - adverse effects | Aged | Antiviral agents | Complications and side effects | Dosage and administration | Research | Drug therapy | Hepatitis C | Liver cirrhosis | Risk factors | Genotype & phenotype | Hepatitis | Protease inhibitors | Medical treatment | Viral infections | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9679, pp. 1949 - 1957
Internal Medicine | Biological and medical sciences | General aspects | Medical sciences | United States - epidemiology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Thailand - epidemiology | Uterine Cervical Neoplasms - epidemiology | Vaccination - adverse effects | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Incidence | Vaccination - methods | Philippines - epidemiology | Papillomavirus Vaccines - adverse effects | Adult | Female | Papillomavirus Infections - virology | Safety | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - complications | Colombia - epidemiology | Double-Blind Method | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Europe - epidemiology | Alphapapillomavirus | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Prevention | Women | Research | Papillomavirus infections | Health aspects | Risk factors | Health facilities | Human papillomavirus | Immunization | Biomedical research | Womens health | Clinical trials | Vaccines | Product safety | Drug therapy | Cervical cancer | Index Medicus | Abridged Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 49, pp. 6244 - 6257
Allergy and Immunology | Human Papillomavirus | Vaccines | Cancer | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Microbiology | Applied microbiology | Biological and medical sciences | Medical sciences | Virology | Tumors | Humans | Neoplasms, Squamous Cell - prevention & control | Cost of Illness | Genital Neoplasms, Female - prevention & control | Male | Uterine Cervical Neoplasms - pathology | Condylomata Acuminata - prevention & control | Young Adult | Vulvar Neoplasms - pathology | Condylomata Acuminata - immunology | Neoplasms, Squamous Cell - immunology | Vaginal Neoplasms - prevention & control | Immunization Programs | Adult | Female | Rectal Neoplasms - immunology | Neoplasms, Squamous Cell - pathology | Papillomavirus Infections - transmission | Vulvar Neoplasms - immunology | Papillomavirus Vaccines - therapeutic use | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Neoplasms - pathology | Genital Neoplasms, Female - immunology | Rectal Neoplasms - prevention & control | Papillomavirus Infections - economics | Animals | Vulvar Neoplasms - prevention & control | Adolescent | Papillomavirus Vaccines - immunology | Vaginal Neoplasms - immunology | Genital Neoplasms, Female - pathology | Warts | Papillomavirus infections | Cervical cancer | Human papillomavirus | Immunization | Womens health | Index Medicus
Journal Article
Journal of gastroenterology, ISSN 0944-1174, 05/2018, Volume 53, Issue 5, pp. 679 - 688
Hepatitis | Therapy | Retrospective | Quinoxalines - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Hepatitis C, Chronic - complications | Coinfection - complications | Viral Load | Young Adult | Clinical Trials, Phase III as Topic | Adult | Female | Retrospective Studies | Imidazoles - therapeutic use | Quinoxalines - therapeutic use | Benzofurans - therapeutic use | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Viral Nonstructural Proteins - genetics | Genotype | Hepatitis C, Chronic - drug therapy | Benzofurans - adverse effects | Drug Resistance, Viral - genetics | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | Adolescent | HIV Infections - complications | Aged | Liver Cirrhosis - physiopathology | Sustained Virologic Response | Clinical Trials, Phase II as Topic | Genetic aspects | Hepatitis C virus | Health aspects | Analysis | Cirrhosis | Chronic infection | Clinical trials | Data processing | Infections | Hepatitis C | Ribonucleic acid--RNA | Genotypes | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Quinoxalines - adverse effects | Recurrence | Opioid-Related Disorders - drug therapy | Humans | Middle Aged | Drug Resistance, Viral | Methadone - therapeutic use | Male | Hepatitis C, Chronic - complications | Young Adult | Substance Abuse, Intravenous - drug therapy | Adult | Female | Opiate Substitution Treatment | Imidazoles - therapeutic use | Quinoxalines - therapeutic use | Benzofurans - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Genotype | Hepatitis C, Chronic - drug therapy | Benzofurans - adverse effects | Medication Adherence | Buprenorphine - therapeutic use | Antiviral Agents - adverse effects | Adolescent | Buprenorphine, Naloxone Drug Combination - therapeutic use | Aged | Hepatitis C, Chronic - genetics | Drug Combinations | Opioid-Related Disorders - complications | Physiological aspects | Drug addicts | Hepatitis C | Drug therapy | Clinical trials | Hepatitis | Narcotics | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 5, pp. 401 - 411
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Prevention and actions | Double-Blind Method | Humans | Papillomavirus Infections - epidemiology | Male | Treatment Outcome | Genital Diseases, Male - epidemiology | Genital Diseases, Male - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Incidence | Alphapapillomavirus | Young Adult | Injections - adverse effects | Papillomavirus Infections - prevention & control | Adolescent | Intention to Treat Analysis | Papillomavirus Vaccines - adverse effects | Adult | Papillomavirus Infections - virology | Genital Diseases, Male - virology | Prevention | Papillomavirus infections | Genital diseases, Male | Human papillomavirus | Infections | Vaccines | Males | Females | Cervical cancer | Manuscripts | Index Medicus | Abridged Index Medicus
Journal Article